RNARevive earns further acclaim during year of momentum

The Berlin-based Falling Walls Foundation is the latest organization to recognize the work of RNARevive, placing it on its list of the 100 Science Startups to Watch. Falling Walls, which supports the intersection of science and business, selected the company from 597 nominations. The 25 finalists who will pitch at the Falling Walls Science Summit in November will be announced on Aug. 11.

RNARevive is developing a platform to deliver self-amplifying RNA therapeutics, starting with ones targeting age-related bone health. These types of therapeutics can reduce the number of doses required to treat patients, thus saving time and money in care. The company put it poetically in its Falling Walls bio: "RNARevive uses RNA technology to turn your body into a medicine-making machine. Our platform cuts the cost of advanced therapies and puts them within reach of more patients."

This is far from the first time RNARevive has received acclaim since the seeds for the company were planted by CEO and founder Mardin Falla's research at the University of Alberta in 2023. In 2025, he was awarded up to $250,000 through the Innovation Catalyst Grant. This year, the company welcomed co-founder and head of business Nina Karpoff with help from UCeed. It made the finale of a Startup TNT investment summit, was selected for Plug and Play's Lifetech Batch 2 in the United States, and made Scale Up Canada's Edmonton50 list. Meanwhile, Karpoff has joined the first cohort of Edmonton Unlimited's Wired for Potential program for women tech founders and leaders.